Results 141 to 150 of about 22,035 (254)

Resource Use and Cost Associated With Cardiovascular, Renal, Bone, and Neuropsychiatric Comorbidities in People With HIV in Spain. [PDF]

J Health Econ Outcomes Res
Ventayol P, Dueñas C, Martín C, Castro A, Citoler B, Vidal-Vilar N.   +5 more
europepmc   +1 more source

The dolutegravir failure cohort: A multi-country longitudinal cohort with a randomised clinical trial of continued dolutegravir versus switch to darunavir in people with viraemia while on dolutegravir in Sub-Saharan Africa (The Ndovu Study) protocol. [PDF]

PLoS One
Ombajo LA, Nkuranga J, Penner J, Kamau EW, Ismael N, Munseri P, Ayakaka I, Labhardt N, Wamalwa D, Ramgi P, Chissumba RM, Wagude J, Bakari M, Omodi V, Otieno E, Abuogi L, Patel R, Opondo C, Grint D, King'wara L, Macharia A, Mulwa A, Amoth P, Ndovu study group.   +23 more
europepmc   +1 more source

Highly Potent Phosphinic HIV‑1 Protease Inhibitors: Synthesis, In Vitro Evaluation, and Docking Studies. [PDF]

ACS Omega
Hayat K, Qiu D, Wang Y, Imbenzi PS, Khan FI, Matziari M.   +5 more
europepmc   +1 more source

To Switch or not to Switch: are there any Antiretroviral Strategies to Attenuate Weight Gain in People with HIV? [PDF]

Curr HIV/AIDS Rep
Debroy P, Lake JE.
europepmc   +1 more source

Darunavir/Cobicistat [PDF]

, 2020
openaire   +1 more source

Effectiveness of simplified ART regimens in older adults living with HIV: real-world evidence from a Brazilian cohort. [PDF]

Braz J Med Biol Res
Stanicki PV, Tasca KI, Zimmerman WR, Barbosa AN.   +3 more
europepmc   +1 more source

2025 US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Post-exposure Prophylaxis in Healthcare Settings. [PDF]

Infect Control Hosp Epidemiol
Kofman AD, Struble KA, Heneine W, Gayle B, de Perio MA, Okasako-Schmucker DL, So CN, Anderson LE, Stone EC, Henderson DK, Kuhar DT.   +10 more
europepmc   +1 more source

Darunavir analog precursors target mitochondrial metabolism in multiple myeloma and CLL. [PDF]

Cancer Cell Int
Mecca M, Sichetti M, Spina E, Giuseffi M, Giglio E, Picerno S, Valvano L, Statuto T, Santarsiere A, Funicello M, Armentano MF, Chiummiento L, Lupattelli P, Romano A, Giordano A, Cortellino S.   +15 more
europepmc   +1 more source

Long-acting Cabotegravir/Rilpivirine for Treatment of HIV During Pregnancy: A Case Series. [PDF]

Open Forum Infect Dis
Sunagawa SW, Floyd CC, Bares SH, Podany AT, Scarsi KK, Mykris T, Winchester L, O'Neill J, Kubat M, Tran C, Davis JM, Snyder JW, Havens JP.   +12 more
europepmc   +1 more source

Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries With the Highest Adult HIV Prevalence. [PDF]

Clin Infect Dis
Nutt CT, Lessells RJ, Muyindike WR, Johnson LS, Kouyos RD, Loosli T, Ombajo LA, Brijkumar J, Hyle EP, Moosa MS, Gandhi M, Vitoria MAA, Jordan MR, Siedner MJ, McCluskey SM.   +14 more
europepmc   +1 more source